CPT-11 or weekly PTX and Trastuzumab for previously treated HER2 positive advanced gastric cancer -Phase II study

Trial Profile

CPT-11 or weekly PTX and Trastuzumab for previously treated HER2 positive advanced gastric cancer -Phase II study

Recruiting
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Irinotecan (Primary) ; Paclitaxel; Trastuzumab
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jan 2013 Additional lead trial centre added as reported by University Hospital Medical Information Network - Japan record.
    • 30 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top